China
· Delayed Price · Currency is CNY Anhui Anke Biotechnology (Group) Statistics
Total Valuation
Anhui Anke Biotechnology (Group) has a market cap or net worth of CNY 15.32 billion. The enterprise value is 14.41 billion.
| Market Cap | 15.32B |
| Enterprise Value | 14.41B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | May 27, 2024 |
Share Statistics
Anhui Anke Biotechnology (Group) has 1.67 billion shares outstanding. The number of shares has increased by 1.62% in one year.
| Shares Outstanding | 1.67B |
| Shares Change (YoY) | +1.62% |
| Shares Change (QoQ) | -1.40% |
| Owned by Insiders (%) | 37.87% |
| Owned by Institutions (%) | 9.99% |
| Float | 1.03B |
Valuation Ratios
The trailing PE ratio is 17.62 and the forward PE ratio is 14.54. Anhui Anke Biotechnology (Group)'s PEG ratio is 0.81.
| PE Ratio | 17.62 |
| Forward PE | 14.54 |
| PS Ratio | 5.31 |
| PB Ratio | 4.04 |
| P/FCF Ratio | 24.20 |
| PEG Ratio | 0.81 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.01, with an EV/FCF ratio of 22.78.
| EV / Earnings | 16.62 |
| EV / Sales | 5.01 |
| EV / EBITDA | 14.01 |
| EV / EBIT | 15.75 |
| EV / FCF | 22.78 |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.92 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.09 |
| Interest Coverage | 360.28 |
Financial Efficiency
Return on equity (ROE) is 23.86% and return on invested capital (ROIC) is 15.31%.
| Return on Equity (ROE) | 23.86% |
| Return on Assets (ROA) | 12.57% |
| Return on Capital (ROIC) | 15.31% |
| Revenue Per Employee | 963,593 |
| Profits Per Employee | 290,357 |
| Employee Count | 2,986 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.30 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.71% in the last 52 weeks. The beta is 0.56, so Anhui Anke Biotechnology (Group)'s price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -3.71% |
| 50-Day Moving Average | 8.32 |
| 200-Day Moving Average | 9.22 |
| Relative Strength Index (RSI) | 57.70 |
| Average Volume (20 Days) | 22,701,177 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anhui Anke Biotechnology (Group) had revenue of CNY 2.88 billion and earned 867.01 million in profits. Earnings per share was 0.52.
| Revenue | 2.88B |
| Gross Profit | 2.25B |
| Operating Income | 915.11M |
| Pretax Income | 948.44M |
| Net Income | 867.01M |
| EBITDA | 1.02B |
| EBIT | 915.11M |
| Earnings Per Share (EPS) | 0.52 |
Balance Sheet
The company has 1.16 billion in cash and 58.21 million in debt, giving a net cash position of 1.10 billion or 0.66 per share.
| Cash & Cash Equivalents | 1.16B |
| Total Debt | 58.21M |
| Net Cash | 1.10B |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 3.95B |
| Book Value Per Share | 2.27 |
| Working Capital | 1.42B |
Cash Flow
In the last 12 months, operating cash flow was 825.88 million and capital expenditures -193.04 million, giving a free cash flow of 632.84 million.
| Operating Cash Flow | 825.88M |
| Capital Expenditures | -193.04M |
| Free Cash Flow | 632.84M |
| FCF Per Share | 0.38 |
Margins
Gross margin is 78.22%, with operating and profit margins of 31.80% and 30.13%.
| Gross Margin | 78.22% |
| Operating Margin | 31.80% |
| Pretax Margin | 32.96% |
| Profit Margin | 30.13% |
| EBITDA Margin | 35.46% |
| EBIT Margin | 31.80% |
| FCF Margin | 21.99% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.61%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 2.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 47.68% |
| Buyback Yield | -1.62% |
| Shareholder Yield | 0.98% |
| Earnings Yield | 5.68% |
| FCF Yield | 4.13% |
Stock Splits
The last stock split was on May 14, 2021. It was a forward split with a ratio of 1.2.
| Last Split Date | May 14, 2021 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Anhui Anke Biotechnology (Group) has an Altman Z-Score of 13.12.
| Altman Z-Score | 13.12 |
| Piotroski F-Score | n/a |